Mavcien Trademark Details
Word Mark | Mavcien |
---|---|
Status | Dead 605 — Abandoned - After Publication |
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
235 East 42nd Street
New York, Ny 10017
Serial Number | 77356514 |
---|---|
Status Date | Monday, August 25, 2008 |
Filing Date | Monday, August 25, 2008 |
Attorney | Matthew A. Pater |
Correspondent
MATTHEW A. PATER
PFIZER INC.
150 EAST 42ND STREET
LEGAL DIVISION - TRADEMARK DEPARTMENT
NEW YORK, NY 10017
PFIZER INC.
150 EAST 42ND STREET
LEGAL DIVISION - TRADEMARK DEPARTMENT
NEW YORK, NY 10017
Case File Statements
Goods & Services | Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 8 — Abandoned |
Status Date | Monday, August 25, 2008 |
Primary Code | 005 |
Trademark Timeline
-
Dec 20 2007Trademark application filed with USPTO
-
Dec 27 2007New Application Entered In Tram
-
Mar 17 2008Approved For Pub - Principal Register
-
Mar 17 2008Assigned To Examiner
-
Mar 29 2008Law Office Publication Review Completed
-
Mar 29 2008Assigned To Lie
-
Apr 16 2008Notice of Publication
-
May 06 2008Published For Opposition
-
Jul 29 2008Noa Mailed - Sou Required From Applicant
-
Aug 22 2008Teas Express Abandonment Received
-
Aug 25 2008Abandonment Notice Mailed - After Publication
-
Aug 25 2008Abandonment - After Publication